Non-Invasive Prenatal Testing (NIPT) Market Outlook, Deployment Type and Business Opportunities 2027
Market Research Future (MRFR) expects the non-invasive prenatal testing (NIPT) market to touch USD 8,217.53 MN by 2027. Meanwhile, the market expansion rate is projected to be around 12.8% from 2020 to 2027 (review period).
Escalation in cases of chromosomal abnormalities along with the rising use of Non-invasive prenatal testing devices in a variety of applications could help generate significant revenues in the coming years. Innovations in non-invasive prenatal tests to facilitate higher functions, better bioinformatics analysis and improved chemistry should also spur the business growth. Improvements in reimbursement policies with respect to low-risk and average pregnancies also enhances the market size. For instance, in December 2020, Natera extended its coverage from the biggest U.S. Health Plan named Aetna with respect to its non-invasive prenatal testing, covering every type of pregnancy.
Non-invasive prenatal testing market is increasingly being used among patients above the age of 35 experiencing high-risk pregnancies. Mounting awareness level about chromosomal anomalies like Down syndrome also encourage women to opt for these tests. General Electric Company [GE Healthcare] (US), Perkinelmer, Inc. (US), Illumina, Inc. (US), Beijing Genomics Institute (China), Thermo Fisher Scientific, Inc. (US), Tarsa Therapeutics Inc. (US), PhytoHealth Corporation (Taiwan), Laboratory Corporation of America Holdings (US), Hoffman-La Roche Ltd. (Switzerland), Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG] (Germany), Natera, Inc. (US), Agilent Technologies, Inc. (US), are some of the top companies in the non-invasive prenatal testing industry.
Market Segmentation
To offer a comprehensive framework of the non-invasive prenatal testing industry, the MRFR report has outlined a few major segments, namely product type, techniques, application, and end-user.
- By product type, the global market has been segmented into devices, consumables, and others. The devices segment includes ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.
- By technique, the market has been segmented into biochemical screening tests and ultrasound detection. Among these, the biochemical screening tests segment has a major market share. This is primarily due to the rising cases of diabetes, which is boosting global demand.
- By application, the global market study encompasses trisomy, microdeletion syndrome, and others. The trisomy segment has the largest market share and it is getting traction from the trisomy-related disorders.
- By end users, the global market includes diagnostic centers, hospitals & surgical centers, and others. The diagnostic centers are the leading market segment as it serves as the primary diagnostic point for such a detailed process.
Regional Status
The global industry has been regionally considered for Asia Pacific/APAC and MEA or Middle East & Africa coupled with the Americas as well as Europe.
The American market stands at the top spot and is expected to maintain its lead throughout the analysis period. The market demand is significantly high in Canada and the US, with these countries home to numerous well-established firms offering extensive ranges of non-invasive prenatal testing devices and services.
The Europe frequently conduct non-invasive prenatal testing-based activities, which has been favorable for the market to a large extent. Europe’s strong growth in the global market is the result of the exhaustive research and development activities carried out by leading companies. Government’s support as well as the availability of favorable reimbursement schemes also render significant market growth. Constant launch of technically advanced tests should encourage market expansion in the ensuing years as well.
The Asia Pacific, sensing the host of lucrative opportunities, it is believed that the regional market will progress at the fastest rate in the years to come. On top of that, constant advancements in the healthcare sector, backed by rising investments and the surge in research activities carried out by local firms also enhance the growth potential of the APAC market. Growth in people’s per capita income and the soaring demand for well-equipped medical facilities present attractive opportunities as well. With companies like BGI present in China, the APAC market is bound to exhibit commendable growth in subsequent years.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
